Research Topics
Genomes and GenesSpecies | MARGARET REDFIELDSummaryAffiliation: Mayo Clinic Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Trends in prevalence and outcome of heart failure with preserved ejection fractionTheophilus E Owan
Cardiorenal Research Laboratory, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
N Engl J Med 355:251-9. 2006..These trends underscore the importance of this growing public health problem...
Systolic and diastolic heart failure in the communityFrancesca Bursi
Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, Minn 55905, USA
JAMA 296:2209-16. 2006..Ejection fraction and diastolic dysfunction are independently related to higher levels of BNP. Heart failure with preserved EF is associated with a high mortality rate, comparable to that of patients with reduced EF...
Strategies to screen for stage B as a heart failure prevention interventionMargaret M Redfield
Cardiovascular Division, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA
Heart Fail Clin 8:285-96. 2012..Targeting Stage B HF represents one such potential strategy...
The natriuretic peptides in cardiovascular medicineVijaya K Munagala
Mayo Clinic, Rochester, Minnesota 55905, USA
Curr Probl Cardiol 29:707-69. 2004..The clinical literature regarding the use of recombinant BNP for the treatment of HF is reviewed, underscoring current gaps in our knowledge regarding the indications for and benefits of this novel agent...
Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction: a community-based studyMargaret M Redfield
Guggenheim 9, Mayo Clinic, 200 First St, Southwest, Rochester, MN 55905, USA
Circulation 109:3176-81. 2004..We postulated that plasma brain natriuretic peptide (BNP) might serve as a biomarker for preclinical ventricular dysfunction (PCVD) but that the discriminatory values for BNP may vary with age and sex...
Diastolic heart failure in the communityC Y Hart
Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, 200 First Street, Southwest, Rochester, MN 55905, USA
Curr Cardiol Rep 2:461-9. 2000..This review focuses on the emerging data regarding the prevalence and natural history of diastolic heart failure in the community...
Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemicMargaret M Redfield
Division of Cardiovascular Diseases, Department of Internal Medicine, Guggenheim 9, Mayo Clinic and Foundation, 200 First St SW, Rochester, MN 55905, USA
JAMA 289:194-202. 2003..Yet, the prevalence of diastolic dysfunction and its relation to systolic dysfunction and CHF in the community remain undefined...
Age- and gender-related ventricular-vascular stiffening: a community-based studyMargaret M Redfield
Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, MN, USA
Circulation 112:2254-62. 2005..The prevalence of HFnlEF increases strikingly with age, particularly in women. We hypothesized that ventricular-vascular stiffening may occur with age and be more pronounced in women in the general community...
Plasma brain natriuretic peptide concentration: impact of age and genderMargaret M Redfield
Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
J Am Coll Cardiol 40:976-82. 2002..We wished to examine the effects of age and gender on plasma brain natriuretic peptide (BNP) concentration in a population-based study...
Sildenafil and B-type natriuretic peptide acutely phosphorylate titin and improve diastolic distensibility in vivoKalkidan Bishu
Mayo Clinic Cardiovascular Division, 200 First St SW, Rochester, MN 55905, USA
Circulation 124:2882-91. 2011..We hypothesized that a phosphodiesterase-5A inhibitor (sildenafil) alone or in combination with BNP would increase left ventricular diastolic distensibility by phosphorylating titin...
Membrane guanylyl cyclase receptors: an updateDavid L Garbers
Cecil H and Ida Green Center for Reproductive Biology Sciences, and Department of Pharmacology, Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, TX 75390 9051, USA
Trends Endocrinol Metab 17:251-8. 2006..Some of these receptors also mediate important communication between the heart and intestine, and the kidney to regulate blood volume and Na+ balance...
Nonhypotensive low-dose nesiritide has differential renal effects compared with standard-dose nesiritide in patients with acute decompensated heart failure and renal dysfunctionHenry G Riter
J Am Coll Cardiol 47:2334-5. 2006
Impaired functional status and echocardiographic abnormalities signifying global dysfunction enhance the prognostic significance of previously unrecognized myocardial infarction detected by electrocardiographyKhawaja Afzal Ammar
Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, MN 55905, USA
Ann Noninvasive Electrocardiol 12:27-37. 2007..The relationship between electrocardiographic unrecognized myocardial infarction (UMI), abnormal functional status, echocardiographic abnormalities, and mortality has not been evaluated...
Use of BNP and CRP as biomarkers in assessing cardiovascular disease: diagnosis versus riskVirginia M Miller
Departments of Surgery, Physiology and Biomedical Engineering, Mayo Clinic Rochester, Rochester, MN 55905, USA
Curr Vasc Pharmacol 5:15-25. 2007....
Unexplained pulmonary hypertension in elderly patientsBrian P Shapiro
Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN, USA
Chest 131:94-100. 2007..However, a subset of patients with IPAH is elderly. Our objective was to compare elderly (age >/= 65 years) vs younger persons with unexplained pulmonary hypertension (PH) and a presumptive diagnosis of IPAH...
BNP-induced activation of cGMP in human cardiac fibroblasts: interactions with fibronectin and natriuretic peptide receptorsBrenda K Huntley
Cardiorenal Research Laboratory, Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, MN 55904, USA
J Cell Physiol 209:943-9. 2006..Lastly, the NPR-C may also have a role in mediating anti-proliferative actions of BNP in CFs...
Association of obesity with left ventricular remodeling and diastolic dysfunction in patients without coronary artery diseaseBrian D Powell
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA
Am J Cardiol 98:116-20. 2006..In conclusion, ventricular remodeling, LV diastolic dysfunction, and elevated filling pressures may contribute to the prevalence of heart failure in obese patients...
Diabetes in heart failure: prevalence and impact on outcome in the populationAaron M From
The Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
Am J Med 119:591-9. 2006..DM is associated with a large increase in mortality, particularly among subjects without clinical CAD, underscoring the importance of aggressive management of DM in HF...
Use of ejection fraction tests and coronary angiography in patients with heart failureChristopher E Kurtz
Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
Mayo Clin Proc 81:906-13. 2006..Given the potential benefits of such tests, including more appropriate therapy and more objective monitoring of ventricular function, outcomes in persons with HF may be improved with more consistent use...
Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general populationCarolyn S P Lam
Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
J Am Coll Cardiol 49:1193-202. 2007..This study was designed to determine whether alternate pro-B-type natriuretic peptide (proBNP) and BNP forms circulate in the general population...
Immunoreactivity and guanosine 3',5'-cyclic monophosphate activating actions of various molecular forms of human B-type natriuretic peptideDenise M Heublein
Cardiorenal Research Laboratory, Division of Cardiovascular Diseases, Mayo Clinic and Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Hypertension 49:1114-9. 2007..These findings also demonstrate differential cGMP activating properties of BNP forms and, importantly, that pro-BNP 1-108 and NT-pro-BNP 1-76 have reduced cGMP activity in vitro that may have biological relevance to human heart failure...
Prevalence and prognostic significance of heart failure stages: application of the American College of Cardiology/American Heart Association heart failure staging criteria in the communityKhawaja Afzal Ammar
Division of Cardiovascular Diseases, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
Circulation 115:1563-70. 2007..The prevalence of HF stages and their association with mortality are unknown. We sought to estimate HF stage prevalence in the community and to measure the association of HF stages with mortality...
Advanced glycation end products accumulate in vascular smooth muscle and modify vascular but not ventricular properties in elderly hypertensive caninesBrian P Shapiro
Cardiorenal Research Laboratory, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
Circulation 118:1002-10. 2008..We determined whether and where AGEs were increased in elderly hypertensive nondiabetic dogs and whether an AGE cross-link breaker (ALT-711) improved vascular or ventricular function...
K(ATP) channel polymorphism is associated with left ventricular size in hypertensive individuals: a large-scale community-based studySantiago Reyes
Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic, Rochester, MN, USA
Hum Genet 123:665-7. 2008..These findings implicate Kir6.2 K23 as a risk factor for adverse subclinical myocardial remodeling, and underscore the significance of cardiac K(ATP) channels within the population...
Comparison of echocardiographic dyssynchrony assessment by tissue velocity and strain imaging in subjects with or without systolic dysfunction and with or without left bundle-branch blockChinami Miyazaki
Division of Cardiovascular Diseases, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
Circulation 117:2617-25. 2008..The present study aimed to compare tissue velocity-derived and strain-derived dyssynchrony indexes in patients with or without systolic dysfunction and left bundle-branch block...
The effects of nesiritide on renal function and diuretic responsiveness in acutely decompensated heart failure patients with renal dysfunctionTheophilus E Owan
Mayo Clinic College of Medicine, Division of Cardiovascular Diseases, Rochester, Minneosta 55905
J Card Fail 14:267-75. 2008..We hypothesized that brain natriuretic peptide (nesiritide) added to standard HF therapy would preserve renal function and enhance diuretic responsiveness...
Mineralocorticoid signaling in transition to heart failure with normal ejection fractionBrian P Shapiro
Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, MN, USA
Hypertension 51:289-95. 2008....
Impact of arterial load and loading sequence on left ventricular tissue velocities in humansBarry A Borlaug
Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
J Am Coll Cardiol 50:1570-7. 2007..The aim of this study was to examine the relationship between individual components of left ventricular (LV) afterload and tissue Doppler echocardiography (TDE) velocities in humans...
Response to cardiac resynchronization therapy predicts survival in heart failure: a single-center experienceYong Mei Cha
Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
J Cardiovasc Electrophysiol 18:1015-9. 2007..To determine whether survival after cardiac resynchronization therapy (CRT) is related to improvement in clinical or echocardiographic parameters...
Revisiting methods for assessing and comparing left ventricular diastolic stiffness: impact of relaxation, external forces, hypertrophy, and comparatorsWissam A Jaber
Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, MN 55905, USA
Am J Physiol Heart Circ Physiol 293:H2738-46. 2007..The concordance between these two methods was poorly reflected by comparing the derived alpha and beta but apparent when using EDV(10-30), which provides information regarding the position of the PVR in a single number...
Mineralocorticoid escape by the kidney but not the heart in experimental asymptomatic left ventricular dysfunctionLisa C Costello-Boerrigter
Cardiorenal Research Laboratory, Division of Cardiovascular Diseases, Mayo Clinic and Mayo Clinic College of Medicine, 200 First St SW, Rochester, MN 55905, USA
Hypertension 50:481-8. 2007..Despite renal escape, increased left ventricular collagen deposition suggests that the heart but not the kidney failed to escape the tissue effects of DOCA...
Acute and chronic ventricular-arterial coupling in systole and diastole: insights from an elderly hypertensive modelBrian P Shapiro
Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, MN 55905, USA
Hypertension 50:503-11. 2007..These observations provide insight into the mechanisms whereby arterial remodeling and acute and chronic VA coupling in both systole and diastole may predispose to and interact with increases in load to cause HFnlEF...
Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, MinnesotaCarolyn S P Lam
Division of Cardiovascular Diseases, Mayo Clinic and Foundation, 200 First St SW, Rochester, MN 55905, USA
Circulation 115:1982-90. 2007....
Natriuretic peptides as regulators of myocardial structure and function: pathophysiologic and therapeutic implicationsAlessandro Cataliotti
Cardiorenal Research Laboratory, Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55904, USA
Heart Fail Clin 2:269-76. 2006
Secular trends in renal dysfunction and outcomes in hospitalized heart failure patientsTheophilus E Owan
Cardiorenal Research Laboratory, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
J Card Fail 12:257-62. 2006..However, adjusting for these secular trends in patient characteristics, mortality after HF admission is improving. These data enhance our understanding of the changing natural history of HF...
Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide: biomarkers for mortality in a large community-based cohort free of heart failurePaul M McKie
Cardiorenal Research Laboratory, Mayo Clinic and Foundation, Rochester, MN, USA
Hypertension 47:874-80. 2006....
Unrecognized myocardial infarction: the association with cardiopulmonary symptoms and mortality is mediated via echocardiographic abnormalities of global dysfunction instead of regional dysfunction: the Olmsted County Heart Function StudyKhawaja Afzal Ammar
Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, MN, USA
Am Heart J 151:799-805. 2006..There are very few data describing the association of electrocardiogram-based unrecognized myocardial infarction (ECG-UMI) with nonanginal cardiopulmonary symptoms, echocardiographic abnormalities, and mortality in the community...
Atrial fibrillation and ventricular dysfunction: a vicious electromechanical cycleYong-Mei Cha
Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minn 55905, USA
Circulation 109:2839-43. 2004
Triphasic mitral inflow velocity with middiastolic filling: clinical implications and associated echocardiographic findingsJong-Won Ha
Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA
J Am Soc Echocardiogr 17:428-31. 2004..Triphasic mitral inflow with middiastolic flow is related to elevated filling pressure, delayed myocardial relaxation, and slow heart rate, indicating advanced diastolic dysfunction...
The role of brain natriuretic peptide in population screeningLiselotte N Dyrbye
Department of Medicine, Mayo Clinic and Foundation, Rochester, MN 55905, USA
Heart Fail Rev 8:349-54. 2003..Here we review available population-based studies assessing the predictive characteristics of BNP for the detection of pre-clinical structural heart disease (Stage B Heart Failure)...
Association of newer diastolic function parameters with age in healthy subjects: a population-based studyVijaya K Munagala
Department of Health Science Research, Mayo Clinic and Foundation, Rochester, Minnesota, USA
J Am Soc Echocardiogr 16:1049-56. 2003..CONCLUSIONS: All newer Doppler diastolic function parameters showed a variable but significant correlation with age. Age-specific reference values will aid in the interpretation of diastolic function parameters...
Incidence of heart failure after myocardial infarction: is it changing over time?Jens P Hellermann
Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
Am J Epidemiol 157:1101-7. 2003..This suggests that improved survival after MI is unlikely to be a major contributor to the heart failure epidemic...
Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failureHorng H Chen
Cardiorenal Research Laboratory, Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota 55905, USA
Am J Physiol Renal Physiol 284:F1115-9. 2003..These findings support the use of AT(1) receptor blockade for human CHF requiring acute diuretics to improve renal hemodynamic and tubular function and to suppress aldosterone...
Left atrial volume as an index of left atrial size: a population-based studyAllison M Pritchett
Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA
J Am Coll Cardiol 41:1036-43. 2003..Further, we find that in the community, left atrial enlargement is common and reflects the burden of cardiovascular disease...
Failing atrial myocardium: energetic deficits accompany structural remodeling and electrical instabilityYong-Mei Cha
Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
Am J Physiol Heart Circ Physiol 284:H1313-20. 2003..Myocardial bioenergetic deficits are a conserved feature of dysfunctional atrial and ventricular myocardium in CHF and may constitute a component of the substrate for AF in CHF...
Diastolic heart failure in the community: clinical profile, natural history, therapy, and impact of proposed diagnostic criteriaHorng H Chen
Division of Cardiovascular Diseases and the Department of Health Sciences Research, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
J Card Fail 8:279-87. 2002..CONCLUSION: This population-based study provides a comprehensive clinical profile, current management, prognosis, and predictors of outcome of patients with new onset CHF who had normal ejection fraction...
Hemodynamic and humoral effects of vasopeptidase inhibition in canine hypertensionCalin V Maniu
Division of Cardiovascular Diseases, Mayo Clinic and Mayo Foundation, Rochester, Minn 55905, USA
Hypertension 40:528-34. 2002..Synergistic effects on humoral and probably endothelial vasodilatory factors appear to be important in mediating the unique hemodynamic profile of vasopeptidase inhibition in this form of experimental hypertension...
The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failureShang-Chiun Lee
Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
J Card Fail 8:149-54. 2002..Given that clinical assessment of CHF is subjective, plasma BNP is a useful objective biomarker in monitoring human CHF in the outpatient setting...
The Breathing Not Proper trial: enough evidence to change heart failure guidelines?Margaret M Redfield
Cardiorenal Laboratory, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
J Card Fail 8:120-3. 2002
Trends in heart failure incidence and survival in a community-based populationVeronique L Roger
Division of Cardiovascular Diseases and Internal Medicine, Department of Health Sciences Research, Mayo Clinic and Foundation, Rochester, Minn 55095, USA
JAMA 292:344-50. 2004..The epidemic of heart failure has yet to be fully investigated, and data on incidence, survival, and sex-specific temporal trends in community-based populations are limited...
Mitral regurgitation in patients with advanced systolic heart failureJeetendra B Patel
Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
J Card Fail 10:285-91. 2004..CONCLUSION: Among patients with advanced CHF, hemodynamically significant MR is common. The severity of MR did not provide independent prognostic information in this group recognized to have uniformly high mortality...
Participation bias in a population-based echocardiography studySteven J Jacobsen
Department of Health Sciences Research, Division of Epidemiology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Ann Epidemiol 14:579-84. 2004..76) after adjustment for age, sex, and comorbid conditions. CONCLUSIONS: These results provide some reassurance that participation bias in this study may have little influence on its overall findings, although this cannot be conclusive...
Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunctionLisa C Costello-Boerrigter
Cardiorenal Research Laboratory, Mayo Clinic and Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
J Am Coll Cardiol 47:345-53. 2006..This study sought to characterize factors influencing amino-terminal pro-B-type natriuretic peptide (NT-proBNP) and to evaluate the ability of NT-proBNP to detect left ventricular (LV) dysfunction in a large community sample...
Bioenergetic protection of failing atrial and ventricular myocardium by vasopeptidase inhibitor omapatrilatYong-Mei Cha
Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA
Am J Physiol Heart Circ Physiol 290:H1686-92. 2006..Thus therapy with omapatrilat demonstrates the benefit in protecting phosphotransfer enzyme activities and in preventing impairment of atrial and ventricular bioenergetics in heart failure...
Echocardiographic characteristics of electrocardiographically unrecognized myocardial infarctions in a community populationKhawaja Afzal Ammar
Mayo Clinic and Foundation, Rochester, Minnesota, USA
Am J Cardiol 96:1069-75. 2005..The similar prognosis after UMI and RMI cannot be explained by comparable degrees of ventricular damage...
Effects of omapatrilat on cardiac nerve sprouting and structural remodeling in experimental congestive heart failureYong Mei Cha
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota 55905, USA
Heart Rhythm 2:984-90. 2005..Congestive heart failure (CHF) results in decreased cardiac sympathetic innervation...
Elevated blood pressure and cardiac hypertrophy after ablation of the gly96/IEX-1 geneStacy L Sommer
Department of Internal Medicine, MS 1 120, Mayo Clinic Rochester, Mayo College of Medicine, 200 First St SW, Rochester, MN 55905, USA
J Appl Physiol 100:707-16. 2006..Ablation of the gly96/IEX-1 gene results in hypertension and cardiac hypertrophy, suggesting a novel role for this gene in cardiovascular physiology...
Epidemiology of diastolic heart failureTheophilius E Owan
Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Prog Cardiovasc Dis 47:320-32. 2005....
Natriuretic and antialdosterone actions of chronic oral NEP inhibition during progressive congestive heart failureFernando L Martin
Cardiorenal Research Laboratory, The Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
Kidney Int 67:1723-30. 2005..We also hypothesized that chronic NEPI during progressive CHF (PCHF) would improve the natriuretic response to acute volume expansion...
Cardiac-specific attenuation of natriuretic peptide A receptor activity accentuates adverse cardiac remodeling and mortality in response to pressure overloadJeetendra B Patel
Cardiorenal Research Laboratory, Guggenheim 9, Mayo Clinic, 200 First St, Southwest, Rochester, MN 55905, USA
Am J Physiol Heart Circ Physiol 289:H777-84. 2005....
Ventricular structure and function in aged dogs with renal hypertension: a model of experimental diastolic heart failureVijaya K Munagala
Cardiorenal Research Laboratory, Mayo Clinic and Foundation, Rochester, Minn 55905, USA
Circulation 111:1128-35. 2005..This model mimics many of the structural and functional characteristics described in the limited studies of human DHF and provides insight into the pathogenesis of DHF...
Heart failure after myocardial infarction: clinical presentation and survivalJens P Hellermann
Division of Cardiovascular Diseases and Internal Medicine, Rochester, MN, USA
Eur J Heart Fail 7:119-25. 2005....
Atrial BNP endocrine function during chronic unloading of the normal canine heartOndrej Lisy
Cardiorenal Research Laboratory, Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic and Foundation, 200 First St, SW, Rochester, MN 55905, USA
Am J Physiol Regul Integr Comp Physiol 288:R158-62. 2005....
Acute and chronic reduction of functional mitral regurgitation in experimental heart failure by percutaneous mitral annuloplastyCalin V Maniu
Division of Cardiovascular Disease, Mayo Clinic and Foundation, 200 First Street SW, Rochester, MN 55905, USA
J Am Coll Cardiol 44:1652-61. 2004..11 +/- 4% four weeks after device, p < 0.05) CONCLUSIONS: Percutaneous mitral annuloplasty results in acute and chronic reduction of functional MR in experimental HF...
Actions of a novel synthetic natriuretic peptide on hemodynamics and ventricular function in the dogJohn G Lainchbury
Cardiorenal Research Laboratory, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
Am J Physiol Regul Integr Comp Physiol 282:R993-8. 2002..05), and Tau decreased (31 +/- 2 to 27 +/- 1 ms, P < 0.05). The effects on hemodynamics, LV function, and second messenger generation suggest synthetic DNP may have a role as a cardiac unloading and lusitropic peptide...
Research Grants
- Mayo Heart Failure Regional Clinical CenterMARGARET REDFIELD; Fiscal Year: 2007..Specific Aim 4. Establish a Clinical HF Research Skills Development Core The objective is to train future investigators in clinical HF research facilitating their ability to attain independent status. (End of Abstract) ..
- ISOLATED DIASTOLIC DYSFUNCTIONMARGARET REDFIELD; Fiscal Year: 2007....
- Cyclic GMP And Ventricular Function In Heart FailureMARGARET REDFIELD; Fiscal Year: 2003..abstract_text> ..
- ISOLATED DIASTOLIC DYSFUNCTIONMARGARET REDFIELD; Fiscal Year: 2003....
